课题基金 / 基金详情

Control of c-Myc Function by the Tumor Suppressor p19ARF

Control of c-Myc Function by the Tumor Suppressor p19ARF
肿瘤抑制因子 p19ARF 对 c-Myc 功能的控制
批准号:
6916533
负责人:
STEPHEN R. HANN
金额:
$27.86万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-07-06 至 2009-04-30

项目摘要

项目成果

STEPHEN R. HANN的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):我们已经证明p19 ARF蛋白与c-Myc蛋白结合并共定位,包括外源性和内源性。ARF与c-Myc的结合抑制靶基因的c-Myc反式激活和c-Myc诱导的过度增殖和转化。此外,ARF不抑制c-Myc靶基因的阻遏,实际上似乎是Inr介导的阻遏所必需的,并增强c-Myc诱导的细胞凋亡。ARF还抑制c-Myc的蛋白水解。本建议的重点是进一步说明这种相互作用的特点和功能相关性。我们的假设是ARF与c-Myc的直接相互作用选择性地调节c-Myc蛋白的活性。因此,这一重要检查点控制的丧失将有助于c-Myc功能的失调,导致过度增殖、转化和凋亡抑制。为了检验这一假设,将执行以下具体目标。具体目标I将是表征c-Myc和ARF之间的生化相互作用。具体目标2将是确定介导ARF调节c-Myc活性的分子机制。具体目标3是确定ARF与c-Myc相互作用的生物学作用。我们的新发现和在这些特定目标中提出的实验结果将对c-Myc,ARF和p53的功能产生重大影响。我们的研究结果已经影响了c-Myc分子功能的争议模型,并可能继续影响c-Myc研究的过程,即c-Myc如何在分子水平上发挥作用,以引起对细胞增殖,肿瘤发生和凋亡的强大控制。最后,ARF抑制c-Myc诱导的转化和增强c-Myc诱导的凋亡对癌症治疗具有直接的治疗意义。
英文摘要
DESCRIPTION (provided by applicant): We have shown that p19ARF protein binds and colocalizes with c-Myc protein, both exogenously and endogenously. ARF binding to c-Myc inhibits c-Myc transactivation of target genes and c- Myc-induced hyperproliferation and transformation. Furthermore, ARF does not inhibit repression of c-Myc target genes and actually appears necessary for Inr-mediated repression and enhances c- Myc-induced apoptosis. ARF also inhibits the proteolysis of c-Myc. The further characterization and functional relevance of this interaction is the focus of this proposal. Our hypothesis is that direct ARF interaction with c-Myc selectively regulates the activity of c-Myc protein. Therefore, loss of this important checkpoint control would contribute to deregulation of c-Myc function leading to hyperproliferation, transformation and inhibition of apoptosis. To test this hypothesis the following specific aims will be performed. Specific Aim I will be to characterize the biochemical interaction between c-Myc and ARF. Specific Aim 2 will be to determine the molecular mechanism that mediates the regulation of c-Myc activity by ARF. Specific Aim 3 will be to determine the biological role of the interaction of ARF with c-Myc. Our novel findings and the results of experiments proposed in these specific aims will have major implications for the function of c-Myc, ARF and p53. Our findings have already impacted the controversial model on the molecular function of c-Myc and will likely continue to impact the course of c-Myc studies on how c-Myc functions at the molecular level to elicit such powerful control over cellular proliferation, tumorigenesis and apoptosis. Finally, the inhibition of c-Myc-induced transformation and enhancement of c-Myc-induced apoptosis by ARF has direct therapeutic significance for cancer treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integrated Biological Systems Training in Oncology
  • 批准号:
    8551189
  • 项目类别:
  • 资助金额:
    $39.02万
  • 财政年份:
    2008
  • 负责人:
    STEPHEN R. HANN
  • 依托单位:
Integrated Biological Systems Training in Oncology
  • 批准号:
    7858526
  • 项目类别:
  • 资助金额:
    $42.06万
  • 财政年份:
    2008
  • 负责人:
    STEPHEN R. HANN
  • 依托单位:
Integrated Biological Systems Training in Oncology
  • 批准号:
    9404542
  • 项目类别:
  • 资助金额:
    $1.28万
  • 财政年份:
    2008
  • 负责人:
    STEPHEN R. HANN
  • 依托单位:
Integrated Biological Systems Training in Oncology
  • 批准号:
    7626729
  • 项目类别:
  • 资助金额:
    $41.78万
  • 财政年份:
    2008
  • 负责人:
    STEPHEN R. HANN
  • 依托单位:
海外基金